ES2108350T3 - Procedimiento para la preparacion de 5-arilhidantoinas. - Google Patents

Procedimiento para la preparacion de 5-arilhidantoinas.

Info

Publication number
ES2108350T3
ES2108350T3 ES94115663T ES94115663T ES2108350T3 ES 2108350 T3 ES2108350 T3 ES 2108350T3 ES 94115663 T ES94115663 T ES 94115663T ES 94115663 T ES94115663 T ES 94115663T ES 2108350 T3 ES2108350 T3 ES 2108350T3
Authority
ES
Spain
Prior art keywords
compound
preparation
instituted
arilhidantoinas
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94115663T
Other languages
English (en)
Spanish (es)
Inventor
Hiroshi Yasuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Resonac Holdings Corp
Original Assignee
Showa Denko KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Showa Denko KK filed Critical Showa Denko KK
Application granted granted Critical
Publication of ES2108350T3 publication Critical patent/ES2108350T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/74Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES94115663T 1993-10-06 1994-10-05 Procedimiento para la preparacion de 5-arilhidantoinas. Expired - Lifetime ES2108350T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25076993 1993-10-06
JP25077093 1993-10-06

Publications (1)

Publication Number Publication Date
ES2108350T3 true ES2108350T3 (es) 1997-12-16

Family

ID=26539914

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94115663T Expired - Lifetime ES2108350T3 (es) 1993-10-06 1994-10-05 Procedimiento para la preparacion de 5-arilhidantoinas.

Country Status (3)

Country Link
EP (1) EP0647630B1 (fr)
DE (1) DE69405671T2 (fr)
ES (1) ES2108350T3 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0001319A1 (fr) * 1977-08-18 1979-04-04 Beecham Group Plc Procédé de préparation de l'hydroxyphénylhydantoine et de l'hydroxyphénylglycine et composés ainsi obtenus

Also Published As

Publication number Publication date
DE69405671T2 (de) 1998-02-12
DE69405671D1 (de) 1997-10-23
EP0647630A1 (fr) 1995-04-12
EP0647630B1 (fr) 1997-09-17

Similar Documents

Publication Publication Date Title
UA39099C2 (uk) Циклічні азотовмісні похідні, суміш їх ізомерів або окремі ізомери, або їх солі
MX9203396A (es) Monohidrato de furoato de mometasona, proceso para producirlo y composiciones farmaceuticas.
AR003962A1 (es) Dihidrodibenzo/b,f/azepinas útiles en el tratamiento de algunos desórdenes del sistema nervioso central y períferico, método para preparar dichos compuestos y sus composiciones farmacéuticas,y, sus usos
NO954320D0 (no) Lyosfærer omfattende gonadotropin
BR0112030A (pt) Novos compostos que possuem atividade antibacteriana, antifúngica ou antitumor
BR0307833A (pt) Sìntese controlada de ziprasidona e suas composições
ZA979961B (en) 5-HT1F agonists
MY139206A (en) Pharmaceuticals compositions comprising mycophenolic acid or mycophenolate salt
TWI268278B (en) 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses
IT1265101B1 (it) Derivati dell'acido 2-ammino-4-fenil-4-osso butirrico
ES2108228T3 (es) Factor de diferenciacion de megacariocitos.
BG104776A (en) Method for the production of phenol, methylethylketone and acetone
ES2026314A6 (es) Procedimiento para obtener una composicion profilactica antimicrobiana oftalmica neonatal.
BR9912556A (pt) Triazolpiridinas para o tratamento de distúrbios trombóticos
AU2001260077A1 (en) Microfiltration using activated carbon
BR9807447A (pt) Cobertura para objetos que entram em contato com artigos de vidro durante o seu processo de moldagem
UY26494A1 (es) " estabilización de vino"
PT1091970E (pt) Processo para a preparacao de aloina por extraccao
ES2108350T3 (es) Procedimiento para la preparacion de 5-arilhidantoinas.
GB9828020D0 (en) Synthesis of heteropolyacids
UY27394A1 (es) Pedidos con actividad anti- angiogéna.
BR9907340A (pt) Ciclo-heptenos substituìdos, e processo para a produção de um composto
DE50006244D1 (en) Neue substituierte 3-phenoxy- und 3-phenylalkyloxy-2-phenyl-propylamine
ES2147601T3 (es) Procedimiento para la preparacion de 3-amino-2-cloro-4-alquil-piridinas o 3-amino-2-cloro-4-cicloalquil-piridinas.
ES2156319T3 (es) Derivados de 10,11-dihidro-10-oxo-5h-dibenz/b,f/azepin-5-carboxamida.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 647630

Country of ref document: ES